Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Dicerna Pharmaceuticals Inc.
Sponsor

Dicerna Pharmaceuticals Inc.

United States 75 Hayden Avenue, 02421-7994, United States

About the sponsor

Clinical research activity is centered on primary hyperoxaluria, with a focus on PH1 and the kidney-related complications that accompany the disorder.

  • Oxalate reduction
  • Renal impairment
  • Dialysis-associated care

Interest extends to patients with severe kidney dysfunction, including those receiving hemodialysis or peritoneal dialysis.

About Specializations

Dicerna Pharmaceuticals Inc. runs clinical trials in conditions such as Primary hyperoxaluria, Hyperoxaluria, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Primary hyperoxaluria

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Nedosiran
  • Sponsor:Dicerna Pharmaceuticals Inc.

Hyperoxaluria

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Nedosiran
  • Sponsor:Dicerna Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.